Neurovascular Devices Market by Product (Embolization (Coil, Flow Diverter), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters), Pathology (Stroke, Aneurysm, CAS, AVM) End User (Hospital, ASC) & Region - Global Forecasts to 2026
Updated on : March 24, 2023
The global neurovascular devices market in terms of revenue was estimated to be worth $2.5 billion in 2021 and is poised to reach $3.8 billion by 2026, growing at a CAGR of 8.6% from 2021 to 2026.
Expansion of healthcare infrastructure across the emerging markets, growing adoption of novel neurovascular devices, and greater research in the field of neurovascular therapies are high growth prospects for the neurovascular devices/ interventional neurology market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
Neurovascular Devices Market Dynamics
Drivers: Increasing R&D investments in the pharmaceutical and biotechnology industry
Neurosurgeons and medical professionals are increasingly looking at therapeutic alternatives that can effectively reduce the risk of fatality or severity of neurovascular diseases in patients. With a growing number of patients suffering from neurovascular diseases (such as epilepsy, brain stroke, and cerebral aneurysm) and rising severity of medical conditions (such as hemorrhage and local infections) in target patients, the demand for effective neurovascular treatments is continuously rising across key markets such as the US, Germany, Japan, China, and India. For instance, a cerebral aneurysm is a common neurovascular disorder across the globe. This condition has a significant risk of hemorrhage or permanent neurological damage associated with it. As of 2020, ~6.5 million brain aneurysm cases were reported in the US; moreover, ~30,000 people in the US suffer brain aneurysm rupture every year.
Restraints: High procedural cost of neurovascular surgeries and related products
The high cost of neurovascular surgical procedures and devices is a major factor restraining the global neurovascular devices market, especially in developing countries with poor reimbursement policies. The average cost of standard procedures to treat aneurysm and artery disorders is USD 45,000 to USD 50,000 in the US. Additionally, maintenance costs and other associated indirect expenses increase the total cost of ownership of these devices, thereby limiting their adoption. Small hospitals and standalone ASCs are less inclined to invest in costly and sophisticated technologies due to budgetary constraints; this is more prominent in developing countries. Owing to high costs and a poor reimbursement scenario, a very limited pool of patients in developing countries can afford neurological treatment. As a result, healthcare facilities are reluctant to invest in new or technologically advanced systems, thus limiting the neurovascular devices market.
Opportunities: Rise in demand for minimally invasive neurosurgical procedures
Minimally invasive medical procedures offer significant clinical advantages over conventional surgical procedures, such as shorter hospital stay, faster patient recovery, higher procedural safety & efficacy, and greater affordability. Thus, the market acceptance and demand for endoscopic and other minimally invasive surgical procedures is growing among medical professionals across the world. Geriatric individuals are more susceptible to neurological & neurovascular diseases and prefer treatment procedures that offer easy diagnosis, easy procedures, higher safety, the least possible hospital stay, better efficacy, and reasonable prices. Additionally, aging also increases the incidence of adverse thrombotic events such as pulmonary embolism, stroke, and epilepsy, which can require neurosurgical interventions. Moreover, arteriovenous malformations also lead to hemorrhages and seizures, commonly reported among individuals aged 40 years and above (Source: Medscape). Thus, the rising geriatric population and demand for minimally invasive procedures are expected to offer significant growth opportunities for prominent as well as emerging market players in the field of interventional neurology devices.
Challenges: Stringent regulations
Several key neurovascular device manufacturers (such as Stryker and Medtronic Plc) have been successful in the development and subsequent commercialization of their respective products during the last decade. These products were primarily intended for interventional use during neurovascular surgeries. However, across the mature markets (particularly in the US), the developmental pipeline for interventional neurology products is affected mainly by pricing pressure faced by the key product manufacturers as a result of unsupportive government reforms undertaken in the last three years. Some of these unsupportive government regulations and reforms include the following:
- The Patient Protection and Affordable Care Act that was suspended for a two-year period commencing January 1, 2018, got reinstated in 2020. The law imposes a 2.3% excise tax on the sale in the US of certain medical devices by a manufacturer, producer, or importer.
- Regulatory laws in the US require substantial scientific evidence for clinical trials conducted on human subjects to confirm the safety, efficacy, & risk profile of specific medical devices intended for a particular therapeutic application (including for neurovascular intervention).
The aneurysm coiling & embolization devices segment is expected account for the largest share of the neurovascular devices market during the forecast period.
On the basis of product, the interventional neurology market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neuro thrombectomy devices. The aneurysm coiling & embolization devices product segment, by type, is further segmented into embolic coils, flow diversion devices, and liquid embolic agents. The aneurysm coiling & embolization devices segment is estimated to account for the largest share of the neurovascular devices market, by product, in 2021, owing to growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.
The cerebral aneurysm segment is estimated to account for the largest share of the global neurovascular devices market during the forecast period.
On the basis of pathology, the market is segmented into ischemic strokes, cerebral aneurysm, carotid artery stenosis, arteriovenous malformations & fistulas, and other diseases (including cavernous malformations and Moyamoya disease, among others). The cerebral aneurysm segment is estimated to account for the largest share of the global interventional neurology market, by pathology, in 2021, led by the growing adoption of minimally invasive neurosurgical procedures among neurosurgeons, increasing healthcare expenditure in emerging countries, and increasing incidence of risk factors (such as high blood pressure, cigarette smoking, high cholesterol, diabetes, and obesity).
The ambulatory care centers segment of neurovascular devices market is expected to grow at the highest CAGR during the forecast period.
Based on end-user, the market has been segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories, and academic institutes. As of 2020, hospitals & surgical centers are estimated to account for the largest share of the global market in 2021, while ambulatory care centers are projected to register the highest CAGR during the forecast period. Growing patient preference for minimally invasive medical procedures, rising number of ambulatory surgery centers across developed countries, along with the ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety, and efficacy of these centers, are the major factors that are expected to drive the growth of this end-user segment in the coming years.
North America is expected to be the largest region for neurovascular devices market during the forecast period.
North America is estimated to be the largest region for neurovascular devices market during the forecast period. The neurovascular devices market in North America is driven primarily by factors such as the significant disease burden, increased number of minimally invasive neurology procedures, and continued expansion of trauma/emergency care facilities in US.
To know about the assumptions considered for the study, download the pdf brochure
The major players in the global market are Johnson & Johnson (US), Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation, BALT (France), Perflow Medical (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (US), Lepu Medical (China), and Cerus Endovascular (US), among others.
Neurovascular Devices Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$2.5 billion |
|
Estimated Value by 2026 |
$3.8 billion |
|
Growth Rate |
Poised to grow at a CAGR of 8.6% |
|
Largest Share Segments |
The aneurysm coiling & embolization devices, The cerebral aneurysm and The ambulatory care centers |
|
Market Report Segmentation |
Product, Disease Pathology, End-User, and Region |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
This research report categorizes the neurovascular devices market into following segments & sub-segments:
By Technology
-
Aneurysm coiling & embolization devices
-
Embolic coils
- Bare detachable coils
- Coated detachable coils
- Flow diversion devices
- Liquid embolic agents
-
Embolic coils
-
Cerebral balloon angioplasty & Stenting systems
- Carotid artery stents
- Embolic protection devices
- Balloon catheters
- Support devices
-
Neurothrombectomy devices
- Clot retrievals
- Suction & aspiration devices
- Snares
By Disease Pathology
- Ischemic Strokes
- Cerebral Aneuryms
- Carotid Artery Stenosis
- Arteriovenous Malformations and Fistulas
- Other Diseases
By End Users
- Hospitals & surgical centers
- Ambulatory care centers
- Research laboratories & academic institutes
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Recent Developments
- In 2020, Johnson & Johnson launched Cerenovus Stroke Solutions, which includes a suite of three devices designed to aid physicians in clot removal procedures. The devices include the Cerenovus Large Bore Catheter, Cerebase DA Guide Sheath, and Embotrap III Revascularization Device
- In 2021, Penumbra partnered with Genesis MedTech to expand the neurovascular market in China.
- In 2021, Pehnox established a new entity in the UK in light of Brexit to strengthen its footprint in the key markets across Europe.
Frequently Asked Questions (FAQs):
What is the projected market value of the global Neurovascular Devices Market?
The global market of Neurovascular Devices is projected to reach USD 3.8 billion.
What is the estimated growth rate (CAGR) of the global Neurovascular Devices Market for the next five years?
The global Neurovascular Devices Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.6 % from 2021 to 2026
What are the major revenue pockets in the Neurovascular Devices Market currently?
North America is estimated to be the largest market for neurovascular devices during the forecast period. The neurovascular devices market in North America is driven primarily by factors such as the significant disease burden, increased number of minimally invasive neurology procedures, and continued expansion of trauma/emergency care facilities in US.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 NEUROVASCULAR DEVICES MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 VOLUME-BASED MARKET ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: INTERVENTIONAL NEUROLOGY MARKET
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 COVID-19 HEALTH ASSESSMENT
2.4 COVID-19 ECONOMIC ASSESSMENT
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE NEUROVASCULAR DEVICES MARKET
2.7 DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION
2.8 RESEARCH ASSUMPTIONS
2.9 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 11 NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GLOBAL MARKET SIZE, BY DISEASE PATHOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 13 HOSPITALS & SURGICAL CENTERS TO LEAD IN NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY APPLICATIONS DURING THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4 PREMIUM INSIGHTS (Page No. - 49)
4.1 NEUROVASCULAR DEVICES MARKET OVERVIEW
FIGURE 15 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET DEMAND FOR INTERVENTIONAL NEUROLOGY PRODUCTS
4.2 EUROPE: MARKET
FIGURE 16 EUROPE: ANEURYSM COILING & EMBOLIZATION DEVICES TO LEAD NEUROVASCULAR DEVICES MARKET
4.3 GLOBAL PRODUCT MARKET, BY REGION
FIGURE 17 EMBOLIC COILS TO LEAD THE GLOBAL MARKET
4.4 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY
FIGURE 18 CEREBRAL ANEURYSM TO DOMINATE NEUROVASCULAR DEVICES/ INTERVENTIONAL NEUROLOGY MARKET, BY DISEASE PATHOLOGY, 2021 VS. 2026
4.5 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY COUNTRY
FIGURE 19 CHINA AND INDIA TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
5 MARKET OVERVIEW (Page No. - 54)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 NEUROVASCULAR /INTERVENTIONAL NEUROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Large target patient population
FIGURE 21 PROPORTION OF GERIATRIC POPULATION TO TOTAL WORLD POPULATION, BY COUNTRY, 2020 VS. 2030 (MILLION PEOPLE)
5.2.1.2 Increasing product launches and commercialization
TABLE 2 PRODUCT APPROVALS IN THE NEUROVASCULAR DEVICES MARKET, 2020–2021
5.2.1.3 Favorable reimbursement scenario
TABLE 3 US: REIMBURSEMENT FOR INTERVENTIONAL NEUROLOGY PROCEDURES, 2020
5.2.1.4 Expansion of healthcare infrastructure across emerging markets
FIGURE 22 GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE (GDP): DEVELOPED VS. DEVELOPING COUNTRIES, 2015 VS. 2019
5.2.1.5 Growth in market demand for effective neurovascular devices
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled neurosurgeons
5.2.2.2 High procedural cost of neurovascular surgeries and related products
5.2.3 OPPORTUNITIES
5.2.3.1 Increase in the number of research activities in the field of neurovascular therapies
FIGURE 23 ONGOING CLINICAL TRIALS IN THE GLOBAL MARKET
5.2.3.2 Rise in demand for minimally invasive neurosurgical procedures
5.2.4 CHALLENGE
5.2.4.1 Stringent regulations
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 24 SUPPLY CHAIN ANALYSIS: NEUROVASCULAR DEVICES MARKET, 2020
5.3.1 ROLE IN SUPPLY CHAIN
5.4 ECOSYSTEM ANALYSIS
5.5 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE REGULATION AND DISTRIBUTION STAGES
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 OVERVIEW
TABLE 4 GLOBAL MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.2 THREAT OF NEW ENTRANTS
FIGURE 26 THREAT OF NEW ENTRANTS
5.6.3 THREAT OF SUBSTITUTES
FIGURE 27 THREAT OF SUBSTITUTES
5.6.4 BARGAINING POWER OF SUPPLIERS
FIGURE 28 BARGAINING POWER OF SUPPLIERS
5.6.5 BARGAINING POWER OF BUYERS
FIGURE 29 BARGAINING POWER OF BUYERS
5.6.6 DEGREE OF COMPETITION
FIGURE 30 DEGREE OF COMPETITION
5.7 REGULATORY LANDSCAPE
5.7.1 NORTH AMERICA
5.7.1.1 US
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.7.1.2 Canada
5.7.2 EUROPE
5.7.3 APAC
5.7.3.1 China
5.7.3.2 Japan
5.7.3.3 India
5.7.3.4 South Korea
5.8 REIMBURSEMENT SCENARIO
TABLE 7 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2019
5.9 PRICING TREND ANALYSIS
TABLE 8 AVERAGE PRICE OF NEUROVASCULAR DEVICES, BY COUNTRY, 2020 (USD)
5.10 COVID-19 IMPACT ON NEUROVASCULAR/INTERVENTIONAL NEUROLOGY DEVICES MARKET
5.11 PATENT DETAILS
TABLE 9 PATENT DETAILS
FIGURE 31 PATENT ANALYSIS, 2011–2021
6 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET, BY PRODUCT (Page No. - 80)
6.1 INTRODUCTION
TABLE 10 NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 11 INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (UNITS)
6.2 ANEURYSM COILING & EMBOLIZATION DEVICES
TABLE 12 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 13 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (UNITS)
TABLE 14 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
TABLE 15 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 16 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
6.2.1 EMBOLIC COILS
TABLE 17 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 18 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2019–2026 (USD MILLION)
TABLE 19 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR EMBOLIC COILS, BY REGION, 2019–2026 (UNITS)
6.2.1.1 Bare detachable coils
6.2.1.1.1 Clinical concerns related to the recurrence of brain aneurysms after treatment with bare detachable coils to limit the demand
TABLE 20 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR BARE DETACHABLE COILS, BY REGION, 2019–2026 (USD MILLION)
6.2.1.2 Coated detachable coils
6.2.1.2.1 High product prices to limit adoption in the forecast period
TABLE 21 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR COATED DETACHABLE COILS, BY REGION, 2019–2026 (USD MILLION)
6.2.2 FLOW DIVERSION DEVICES
6.2.2.1 Increase in R&D activities for flow diverters to support demand in the forecast period
TABLE 22 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2019–2026 (USD MILLION)
TABLE 23 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR FLOW DIVERSION DEVICES, BY REGION, 2019–2026 (UNITS)
6.2.3 LIQUID EMBOLIC AGENTS
6.2.3.1 Growth in application in the treatment of AVM & AVF to propel demand
TABLE 24 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2019–2026 (USD MILLION)
TABLE 25 ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE FOR LIQUID EMBOLIC AGENTS, BY REGION, 2019–2026 (UNITS)
6.3 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS
TABLE 26 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 27 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY TYPE, 2019–2026 (UNITS)
TABLE 28 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
TABLE 29 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 30 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS SIZE, BY END USER, 2019–2026 (USD MILLION)
6.3.1 CAROTID ARTERY STENTS
6.3.1.1 Rise in public-private research funding to support innovative product development
TABLE 31 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2019–2026 (USD MILLION)
TABLE 32 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR CAROTID ARTERY STENTS, BY REGION, 2019–2026 (UNITS)
6.3.2 EMBOLIC PROTECTION DEVICES
6.3.2.1 Associated technical limitations to restrain the market growth
TABLE 33 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2019–2026 (USD MILLION)
TABLE 34 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE FOR DISTAL FILTER DEVICES, BY REGION, 2019–2026 (UNITS)
6.3.3 BALLOON CATHETERS
6.3.3.1 Availability of specialized products to support market growth
TABLE 35 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEM MARKET SIZE FOR BALLOON CATHETER, BY REGION, 2019–2026 (USD MILLION)
TABLE 36 CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEM MARKET SIZE FOR BALLOON CATHETER, BY REGION, 2019–2026 (UNITS)
6.4 SUPPORT DEVICES
TABLE 37 NEUROVASCULAR DEVICES MARKET SIZE FOR SUPPORT DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 GLOBAL MARKET SIZE FOR SUPPORT DEVICES, BY TYPE, 2019–2026 (UNITS)
TABLE 39 INTERVENTIONAL NEUROLOGY MARKET SIZE FOR SUPPORT DEVICES, BY REGION, 2019–2026 (USD MILLION)
TABLE 40 SUPPORT DEVICES SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 41 SUPPORT DEVICES SIZE, BY END USER, 2019–2026 (USD MILLION)
6.4.1 MICROCATHETERS
6.4.1.1 Ongoing technological advancements in the field of neurovascular microcatheters to support market growth
TABLE 42 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR MICROCATHETERS, BY REGION, 2019–2026 (USD MILLION)
TABLE 43 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR MICROCATHETERS, BY REGION, 2019–2026 (UNITS)
6.4.2 GUIDEWIRES
6.4.2.1 Higher application in stenting procedures to support market growth
TABLE 44 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR GUIDEWIRES, BY REGION, 2019–2026 (USD MILLION)
TABLE 45 NEUROVASCULAR SUPPORT DEVICES MARKET SIZE FOR GUIDEWIRES, BY REGION, 2019–2026 (UNITS)
6.5 NEUROTHROMBECTOMY DEVICES
TABLE 46 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY TYPE, 2019–2026 (UNITS)
TABLE 48 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
TABLE 49 NEUROTHROMBECTOMY DEVICES SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 50 NEUROTHROMBECTOMY DEVICES SIZE, BY END USER, 2019–2026 (USD MILLION)
6.5.1 CLOT RETRIEVAL DEVICES
6.5.1.1 Greater availability of innovative stent clot retrievers to promote demand in the forecast period
TABLE 51 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR CLOT RETRIEVERS, BY REGION, 2019–2026 (USD MILLION)
TABLE 52 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR CLOT RETRIEVERS, BY REGION, 2019–2026 (UNITS)
6.5.2 SUCTION & ASPIRATION DEVICES
6.5.2.1 Development and commercialization of novel devices to support market growth
TABLE 53 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2019–2026 (USD MILLION)
TABLE 54 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2019–2026 (UNITS)
6.5.3 SNARES
6.5.3.1 Limited procedural benefits to limit the adoption in the forecast period
TABLE 55 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SNARES, BY REGION, 2019–2026 (USD MILLION)
TABLE 56 NEUROTHROMBECTOMY DEVICES MARKET SIZE FOR SNARES, BY REGION, 2019–2026 (UNITS)
7 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY (Page No. - 115)
7.1 INTRODUCTION
TABLE 57 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 58 GLOBAL MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
7.2 CEREBRAL ANEURYSMS
7.2.1 HIGH RISK OF ANEURYSM RECURRENCE AFTER COILING PROCEDURE TO SUPPORT MARKET GROWTH
TABLE 59 GLOBAL MARKET SIZE FOR CEREBRAL ANEURYSMS, BY REGION, 2019–2026 (USD MILLION)
7.3 ISCHEMIC STROKES
7.3.1 GROWTH IN THE NUMBER OF PATIENTS SUFFERING FROM STROKES TO INCREASE THE DEMAND FOR NEUROVASCULAR DEVICES
TABLE 60 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ISCHEMIC STROKES, BY REGION, 2019–2026 (USD MILLION)
7.4 CAROTID ARTERY STENOSIS
7.4.1 RISE IN THE OCCURENCE OF ARTERY STENOSES TO BOOST THE MARKET
TABLE 61 GLOBAL MARKET SIZE FOR CAROTID ARTERY STENOSIS, BY REGION, 2019–2026 (USD MILLION)
7.5 ARTERIOVENOUS MALFORMATION & FISTULAS
7.5.1 LACK OF SKILLED NEUROSURGEONS CAN RESTRAIN MARKET GROWTH
TABLE 62 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2019–2026 (USD MILLION)
7.6 OTHER DISEASE PATHOLOGIES
7.6.1 INCREASE IN THE PATIENT POPULATION FOR TARGET DISEASES TO BOOST THE MARKET
TABLE 63 GLOBAL MARKET SIZE FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2019–2026 (USD MILLION)
8 NEUROVASCULAR DEVICES MARKET, BY END USER (Page No. - 122)
8.1 INTRODUCTION
TABLE 64 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS & SURGICAL CENTERS
8.2.1 LARGEST END USERS OF NEUROVASCULAR DEVICES
TABLE 65 GLOBAL MARKET SIZE IN HOSPITALS & SURGICAL CENTERS, BY REGION, 2019–2026 (USD MILLION)
8.3 AMBULATORY CARE CENTERS
8.3.1 INCREASE IN THE NUMBER OF ACCS LIKELY TO BOOST THE MARKET
TABLE 66 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE IN AMBULATORY CARE CENTERS, BY REGION, 2019–2026 (USD MILLION)
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
8.4.1 ONGOING DEVELOPMENT OF COST-EFFECTIVE AND TECHNOLOGICALLY ADVANCED DEVICES TO SUPPORT THE GROWTH OF THIS SEGMENT
TABLE 67 GLOBAL MARKET SIZE IN RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
9 NEUROVASCULAR DEVICES MARKET, BY REGION (Page No. - 127)
9.1 INTRODUCTION
TABLE 68 NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
TABLE 69 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 NORTH AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 76 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 77 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
FIGURE 32 NORTH AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SNAPSHOT
9.2.1 US
9.2.1.1 Largest share of the North American market
TABLE 78 US: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 US: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 80 US: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 US: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 82 US: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 US: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 The high incidence of neurovascular diseases to support market growth
TABLE 84 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 85 CANADA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 86 CANADA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 CANADA: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 CANADA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 89 CANADA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 90 EUROPE: NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 91 EUROPE: INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 92 EUROPE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 93 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 EUROPE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 95 EUROPE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 EUROPE: MARKET SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Largest share of the market in Europe in 2020
TABLE 99 GERMANY: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 100 GERMANY: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 101 GERMANY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 GERMANY: CEREBRAL BALLOON ANGIOPLASTY AND STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 103 GERMANY: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 104 GERMANY: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Increase in awareness in the country regarding incidences of strokes
TABLE 105 FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 106 FRANCE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 FRANCE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 FRANCE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 109 FRANCE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 110 FRANCE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.3.3 UK
9.3.3.1 Growth in government initiatives to support market demand
TABLE 111 UK: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 112 UK: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 113 UK: INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 UK: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 115 UK: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 116 UK: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Well-established healthcare infrastructure to aid the growth of the neurovascular devices market
TABLE 117 ITALY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 118 ITALY: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 119 ITALY: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 ITALY: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 ITALY: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 122 ITALY: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rise in the number of clinical trials to support the growth of the neurovascular devices market
TABLE 123 SPAIN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 124 SPAIN: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 125 SPAIN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 SPAIN: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 127 SPAIN: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 SPAIN: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 129 ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 130 ROE: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 131 ROE: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 ROE: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 ROE: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 134 ROE: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.4 APAC
TABLE 135 APAC: NEUROVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 136 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 137 APAC: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 138 APAC: INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 APAC: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 140 APAC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 141 APAC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 142 APAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 143 APAC: MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
FIGURE 33 APAC: NEUROVASCULAR DEVICES MARKET SNAPSHOT
9.4.1 JAPAN
9.4.1.1 Favorable reimbursement policy in the country to support market growth
TABLE 144 JAPAN: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 145 JAPAN: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 146 JAPAN: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 JAPAN: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 148 JAPAN: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 149 JAPAN: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Expansion by key market players in the region to drive market growth
TABLE 150 CHINA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 151 CHINA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 152 CHINA: NEUROVASCULAR DEVICES MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 CHINA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 154 CHINA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 155 CHINA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increase in government initiatives to support the demand for neurovascular devices
TABLE 156 INDIA: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 157 INDIA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 158 INDIA: INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 INDIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 160 INDIA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 161 INDIA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Rise in disease prevalence Australia to augment market demand
TABLE 162 AUSTRALIA: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 163 AUSTRALIA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 164 AUSTRALIA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 165 AUSTRALIA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 166 AUSTRALIA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 167 AUSTRALIA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives to drive the neurovascular devices market
TABLE 168 SOUTH KOREA: MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 169 SOUTH KOREA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 170 SOUTH KOREA: MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 171 SOUTH KOREA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 172 SOUTH KOREA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 173 SOUTH KOREA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.4.6 REST OF APAC
TABLE 174 ROAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 ROAPAC: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 176 RAPAC: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 ROAPAC: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 178 ROAPAC: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 179 ROAPAC: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 180 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 181 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 182 LATIN AMERICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 183 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 LATIN AMERICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 185 LATIN AMERICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 186 LATIN AMERICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 187 LATIN AMERICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 188 LATIN AMERICA: MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Increase in awareness about neurovascular devices to increase the demand in Brazil
TABLE 189 BRAZIL: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 190 BRAZIL: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 191 BRAZIL: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 BRAZIL: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 193 BRAZIL: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 194 BRAZIL: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Growth in patient population to lead to market growth
TABLE 195 MEXICO: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 196 MEXICO: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 197 MEXICO: NEUROVASCULAR DEVICES MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 198 MEXICO: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 199 MEXICO: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 200 MEXICO: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 201 ROLATAM: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 202 ROLATAM: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 203 ROLATAM: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 204 ROLATAM: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 205 ROLATAM: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 206 ROLATAM: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 207 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE FOR EMBOLIC COILS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: CEREBRAL BALLOON ANGIOPLASTY & STENTING SYSTEMS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: SUPPORT DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY DISEASE PATHOLOGY, 2019–2026 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 214)
10.1 OVERVIEW
FIGURE 34 KEY PLAYER STRATEGIES
10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.3 MARKET SHARE ANALYSIS
TABLE 215 NEUROVASCULAR DEVICES MARKET: DEGREE OF COMPETITION, 2020
FIGURE 36 STRYKER CORPORATION HELD THE LEADING POSITION IN THE NEUROVASCULAR DEVICES MARKET IN 2020
10.4 COMPETITIVE LEADERSHIP MAPPING (KEY PLAYERS)
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 37 NEUROVASCULAR DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (KEY PLAYERS), 2019
10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES
FIGURE 38 NEUROVASCULAR DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SME, 2020
10.6 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE NEUROVASCULAR DEVICES MARKET
TABLE 216 INDUSTRY AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE NEUROVASCULAR DEVICES MARKET
TABLE 217 COMPANY INDUSTRY FOOTPRINT
TABLE 218 COMPANY REGION FOOTPRINT
10.6.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 219 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS, JANUARY 2018–MARCH 2021
10.6.2 DEALS
TABLE 220 KEY DEALS, JANUARY 2018–MARCH 2021
10.6.3 OTHER DEVELOPMENTS
TABLE 221 OTHER KEY DEVELOPMENTS, JANUARY 2018–MARCH 2021
11 COMPANY PROFILES (Page No. - 227)
(Business overview, Products offered, Recent developments & MnM View)*
11.1 KEY PLAYERS
11.1.1 STRYKER CORPORATION
TABLE 222 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 223 STRYKER CORPORATION: PRODUCT OFFERED
11.1.2 MEDTRONIC PLC
TABLE 224 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 40 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
TABLE 225 MEDTRONIC PLC: PRODUCT OFFERED
11.1.3 JOHNSON & JOHNSON
TABLE 226 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
TABLE 227 JOHNSON & JOHNSON: PRODUCT OFFERED
11.1.4 TERUMO
TABLE 228 TERUMO: BUSINESS OVERVIEW
FIGURE 42 TERUMO: COMPANY SNAPSHOT (2019)
TABLE 229 TERUMO: PRODUCT OFFERED
11.1.5 PENUMBRA
TABLE 230 PENUMBRA: BUSINESS OVERVIEW
FIGURE 43 PENUMBRA: COMPANY SNAPSHOT (2020)
TABLE 231 PENUMBRA: PRODUCT OFFERED
11.1.6 MICROPORT SCIENTIFIC CORPORATION
TABLE 232 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 44 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
TABLE 233 MICROPORT SCIENTIFIC CORPORATION: PRODUCT OFFERED
11.1.7 MEDIKIT CO. LTD.
TABLE 234 MEDIKIT CO. LTD.: BUSINESS OVERVIEW
FIGURE 45 MEDIKIT CO. LTD.: COMPANY SNAPSHOT (2020)
TABLE 235 MEDIKIT CO. LTD.: PRODUCT OFFERED
11.1.8 INTEGERS HOLDING CORPORATION
TABLE 236 INTEGERS HOLDING CORPORATION: BUSINESS OVERVIEW
FIGURE 46 INTEGERS HOLDING CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 237 INTEGERS HOLDING CORPORATION: PRODUCT OFFERED
11.1.9 BALT
TABLE 238 BALT: BUSINESS OVERVIEW
TABLE 239 BALT: PRODUCT OFFERED
11.1.10 KANEKA CORPORATION
TABLE 240 KANEKA CORPORATION: COMPANY AT A GLANCE
FIGURE 47 KANEKA CORPORATION: COMPANY SNAPSHOT (2020)
TABLE 241 KANEKA CORPORATION: PRODUCT OFFERED
11.1.11 PHENOX GMBH
TABLE 242 PHENOX: BUSINESS OVERVIEW
TABLE 243 PHENOX: PRODUCT OFFERED
11.1.12 ASAHI INTECC
TABLE 244 ASAHI INTECC: BUSINESS OVERVIEW
FIGURE 48 ASAHI INTECC: COMPANY SNAPSHOT (2020)
TABLE 245 ASAHI INTECC: PRODUCT OFFERED
11.1.13 PERFLOW MEDICAL
TABLE 246 PERFLOW MEDICAL: BUSINESS OVERVIEW
TABLE 247 PERFLOW MEDICAL: PRODUCT OFFERED
11.1.14 RAPID MEDICAL
TABLE 248 RAPID MEDICAL: BUSINESS OVERVIEW
TABLE 249 RAPID MEDICAL: PRODUCT OFFERED
11.1.15 CERUS ENDOVASCULAR
TABLE 250 CERUS ENDOVASCULAR: BUSINESS OVERVIEW
TABLE 251 CERUS ENDOVASCULAR: PRODUCT OFFERED
11.1.16 ACANDIS GMBH
TABLE 252 ACANDIS GMBH: BUSINESS OVERVIEW
TABLE 253 ACANDIS GMBH: PRODUCT OFFERED
11.1.17 EVASC
TABLE 254 EVASC: BUSINESS OVERVIEW
TABLE 255 EVASC: PRODUCT OFFERED
11.1.18 SENSOME
TABLE 256 SENSOME: BUSINESS OVERVIEW
TABLE 257 SENSOME: PRODUCT OFFERED
11.1.19 LEPU MEDICAL
TABLE 258 LEPU MEDICAL: BUSINESS OVERVIEW
FIGURE 49 LEPU MEDICAL: COMPANY SNAPSHOT (2019)
TABLE 259 LEPU MEDICAL: PRODUCT OFFERED
11.1.20 IMPERATIVE CARE
TABLE 260 IMPERATIVE CARE: BUSINESS OVERVIEW
TABLE 261 IMPERATIVE CARE: PRODUCT OFFERED
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 273)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the neurovascular devices/ interventional neurology market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the total market size. After that, the market breakdown and data triangulation were done to determine the market size of the segments and sub-segments.
Secondary Research
This research study involved the use of extensive secondary sources, directories, and databases, such as Hoover’s, Bloomberg BusinessWeek, Factiva, and OneSource, to identify and collect information useful for a technical, market-oriented, and commercial study of the neurovascular devices/ interventional neurology market. The other secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, manufacturer associations, trade directories, and databases.
Primary Research
The neurovascular devices/ interventional neurology market comprises several stakeholders, such as end-product manufacturers, raw material providers, and end-users in the supply chain. The demand-side of this market is characterized by its end-users, such as hospitals & surgical centers, ambulatory care centers, research & academic institutes, among others. The supply-side is characterized by raw material providers, integrators, and others. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The breakdown of primary respondents are given below:
To know about the assumptions considered for the study, download the pdf brochure
Neurovascular Devices Market Size Estimation
Both top-down and bottom-up approaches have been used to estimate and validate the size of the neurovascular devices market and its dependent submarkets. These methods were also used extensively to determine the extent of various sub-segments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and demand have been identified through extensive secondary research, and their market share has been determined through both primary and secondary research.
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
- All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
- The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the whole market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the end-use industries.
Report Objectives
- To define, describe, and forecast the neurovascular devices/ interventional neurology market based on product, disease pathology, end-user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall neurovascular devices/ interventional neurology market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the revenue of the market segments with respect to five major regions and their countries—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To strategically profile the key global players and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches, upgrades, and approvals; partnerships, agreements, and collaborations; acquisitions; and expansions in the neurovascular devices/ interventional neurology market
- To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes players on various parameters within the broad categories of business and product excellence strategy
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for the neurovascular devices/ interventional neurology market report:
Regional Analysis
- Further breakdown of region or country-specific analysis
Company Information
- Detailed analyses and profiling of additional market players (up to 5)
Growth opportunities and latent adjacency in Neurovascular Devices Market
need data on advancements in the Neurovascular Devices market. outlook, size, share everything.
Detailed US geo information of Neurovascular Devices Market with a vision to 2022 - 2026
In what way COVID19 is Impacting the global growth of the Neurovascular Devices Market?